Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,270 | 320 | 73.6% |
| Gift | $1,709 | 1 | 23.9% |
| Education | $178.60 | 3 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| NxThera, Inc. | $1,723 | 2 | $0 (2017) |
| PFIZER INC. | $811.97 | 63 | $0 (2024) |
| Astellas Pharma US Inc | $767.77 | 44 | $0 (2024) |
| ABBVIE INC. | $534.72 | 33 | $0 (2024) |
| Janssen Biotech, Inc. | $378.18 | 14 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $295.02 | 17 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $217.36 | 14 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $203.39 | 12 | $0 (2024) |
| PROGENICS PHARMACEUTICALS, INC. | $154.36 | 3 | $0 (2024) |
| Merck Sharp & Dohme LLC | $123.38 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $974.94 | 46 | PROGENICS PHARMACEUTICALS, INC. ($135.01) |
| 2023 | $780.55 | 42 | PFIZER INC. ($148.56) |
| 2022 | $853.38 | 46 | Astellas Pharma US Inc ($243.66) |
| 2021 | $446.21 | 25 | Janssen Biotech, Inc. ($79.99) |
| 2020 | $333.06 | 22 | Astellas Pharma US Inc ($57.38) |
| 2019 | $658.42 | 45 | PFIZER INC. ($217.00) |
| 2018 | $750.85 | 57 | PFIZER INC. ($173.24) |
| 2017 | $2,360 | 41 | NxThera, Inc. ($1,723) |
All Payment Transactions
324 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/11/2024 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: Urology Gynecology | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Oncology | ||||||
| 11/14/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: ONCOLOGY | ||||||
| 11/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: Oncology | ||||||
| 11/07/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 11/06/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/05/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: HORMONE THERAPY | ||||||
| 11/04/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: ONCOLOGY | ||||||
| 10/31/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: ONCOLOGY | ||||||
| 10/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: Oncology | ||||||
| 10/17/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: Oncology | ||||||
| 10/04/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/02/2024 | 180 Medical, Inc. | — | Food and Beverage | In-kind items and services | $20.31 | General |
| 09/27/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: Oncology | ||||||
| 09/25/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $26.94 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/06/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $16.17 | General |
| Category: ONCOLOGY | ||||||
| 09/05/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: HORMONE THERAPY | ||||||
| 08/22/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: Oncology | ||||||
| 08/14/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/18/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Diagnostic Imaging | ||||||
| 07/12/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: Oncology | ||||||
| 07/12/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $16.72 | General |
| Category: ONCOLOGY | ||||||
| 07/11/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $120.75 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 06/29/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: BOTOX THERAPEUTIC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 880 | 1,414 | $600,482 | $73,036 |
| 2022 | 11 | 753 | 1,027 | $561,341 | $69,561 |
| 2021 | 16 | 1,047 | 1,501 | $508,200 | $96,995 |
| 2020 | 13 | 832 | 1,182 | $370,026 | $88,650 |
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 149 | 282 | $237,111 | $27,655 | 11.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 152 | 264 | $157,476 | $18,743 | 11.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 51 | 51 | $56,193 | $6,864 | 12.2% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2023 | 63 | 71 | $51,255 | $6,223 | 12.1% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 23 | 26 | $43,269 | $5,804 | 13.4% |
| 76857 | Limited ultrasound scan of pelvis | Office | 2023 | 79 | 93 | $30,548 | $3,613 | 11.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 113 | 155 | $2,772 | $1,286 | 46.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 213 | 421 | $7,139 | $913.00 | 12.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 15 | 20 | $5,921 | $819.55 | 13.8% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 11 | 20 | $4,617 | $600.43 | 13.0% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 11 | 11 | $4,181 | $515.85 | 12.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 143 | 258 | $217,596 | $26,924 | 12.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 155 | 239 | $143,287 | $16,850 | 11.8% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 23 | 27 | $46,224 | $6,115 | 13.2% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2022 | 58 | 60 | $44,347 | $5,566 | 12.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 40 | 40 | $43,835 | $5,366 | 12.2% |
| 76857 | Limited ultrasound scan of pelvis | Office | 2022 | 76 | 93 | $29,891 | $3,806 | 12.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 36 | 38 | $22,686 | $3,009 | 13.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 17 | 20 | $9,040 | $1,240 | 13.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 90 | 115 | $2,067 | $337.20 | 16.3% |
| 81003 | Automated urinalysis test | Office | 2022 | 78 | 98 | $1,666 | $213.43 | 12.8% |
| 81002 | Urinalysis, manual test | Office | 2022 | 37 | 39 | $702.00 | $134.60 | 19.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 175 | 346 | $185,194 | $35,221 | 19.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 179 | 293 | $109,481 | $22,076 | 20.2% |
| 76856 | Ultrasound of pelvis, complete, not pregnancy related | Office | 2021 | 86 | 97 | $50,301 | $8,870 | 17.6% |
About Dr. David Wu, MD
Dr. David Wu, MD is a Urology healthcare provider based in Bloomfield, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1871533844.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Wu, MD has received a total of $7,157 in payments from pharmaceutical and medical device companies, with $974.94 received in 2024. These payments were reported across 324 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($5,270).
As a Medicare-enrolled provider, Wu has provided services to 3,512 Medicare beneficiaries, totaling 5,124 services with total Medicare billing of $328,241. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Bloomfield, NJ
- Active Since 06/07/2006
- Last Updated 11/08/2024
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1871533844
Products in Payments
- Rezum (Device) $1,723
- XTANDI (Drug) $1,034
- PROVENGE (Drug) $332.71
- BOTOX (Biological) $261.24
- ORGOVYX (Drug) $242.98
- ERLEADA (Drug) $234.90
- Myrbetriq (Drug) $212.16
- Xtandi (Drug) $201.95
- PYLARIFY (Drug) $154.36
- ZYTIGA (Drug) $143.28
- Nubeqa (Drug) $133.37
- MYRBETRIQ (Drug) $127.99
- KEYTRUDA (Biological) $123.38
- YONSA (Drug) $120.45
- LUPRON DEPOT (Drug) $115.66
- Androgel (Drug) $113.84
- Lupron (Drug) $101.65
- Xofigo (Drug) $83.99
- PANZYGA (Biological) $67.67
- GEMTESA (Drug) $61.70
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Bloomfield
Elan Diamond, M.d, M.D
Urology — Payments: $55,767
James Zinman, M.d, M.D
Urology — Payments: $14,134
Dr. Matthew Shahbandi, Md, MD
Urology — Payments: $12,908
Dr. Salvatore Lombardo, Md, MD
Urology — Payments: $7,670
Dr. David Franzoni, Md, MD
Urology — Payments: $6,747
Dr. Burton Schlecker, M.d, M.D
Urology — Payments: $6,618